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Abstract Pyruvate carboxylation is of great importance
in the brain since it is responsible for adding net carbons to
the tricarboxylic acid cycle following removal of carbon
backbone for synthesis of the two most abundant neuro-
transmitters, glutamate and GABA. Despite having such a
pivotal role, there is still much uncertainty in the exact
metabolic details about where and how this carbon is
returned. Pyruvate carboxylation has been studied in vari-
ous model systems of the brain and
13C magnetic resonance
spectroscopy is an excellent tool for doing this. This review
will focus on results dealing with the extent and cellular
location of pyruvate carboxylation and its role in patho-
physiology and concludes that pyruvate carboxylation is an
extraordinarily important predominantly astrocytic path-
way which plays a pivotal part in a number of diseases.
Keywords Pyruvate carboxylation  Glucose  Magnetic
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Introduction
There are several enzymes involved in carboxylation in the
brain (Fig. 1); pyruvate carboxylase (PC), phosphoenol-
pyruvate carboxykinase (PEPCK), pyruvate kinase and
malic enzyme (ME) [1]. Some of these enzymes have a cell
speciﬁc localization. Only astrocytes have PC and cytosolic
ME whereas mitochondrial ME and PEPCK have been
found in both neurons and astrocytes [2–9]. The impor-
tance of these enzymes is apparent from the severity of
disease associated with genetic modiﬁcations of these
systems. Mitochondrial malic enzyme (ME2) was found to
be missing in partially complementing genotypes between
lethal deletion alleles at the albino locus in Chromosome 7
of the mouse. Since such partial complementers survive to
adulthood, the absence of normal mitochondrial malic
enzyme is compatible with life [10]. However, it has been
shown that genetic variation in or near the ME2 gene is
associated with both psychotic and manic disorders,
including schizophrenia and bipolar disorder [11].
Pyruvate carboxylase is a nuclear encoded homotetr-
amer found in most eukaryotic and in many prokaryotic
tissues and is a member of the family of biotin-dependent
carboxylases [12]. It is also ATP-dependent and catalyses
the carboxylation of pyruvate to form oxaloacetate [12]. In
mammalian tissues, PC participates in various anabolic
pathways including lipogenesis and the synthesis of neu-
rotransmitter substances [12]. Five alternative forms of rat
pyruvate carboxylase cDNAs have been identiﬁed and
these are expressed in a tissue-speciﬁc manner in liver,
kidney, brain, and adipose tissue [13]. Defects in the
expression or biotinylation of pyruvate carboxylase in
humans is a rare autosomal recessively inherited disorder
of pyruvate metabolism presenting with lactic academia
and neurological involvement and almost invariably results
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retardation [12]. The above clearly reﬂects the vital role PC
plays in intermediary metabolism in many tissues including
the brain [14].
13C magnetic resonance spectroscopy (MRS) is an
excellent tool for the study of metabolic pathways of glu-
cose and other substrates. Using this method and
13C
labeled glucose it could be shown that pyruvate carboxyl-
ation occurs in humans, rats and mice in vivo [15–17]. In
experiments where slices were superfused with
13C labeled
glucose the evidence from MRS analysis of glutamate
suggested that pyruvate carboxylation in slices is minimal
[18–20]. However, using
13C and
15N labeled alanine it
could be shown that carboxylation was taking place in
astrocytes in brain slices [21]. Most cell culture studies also
showed that carboxylation was a glial pathway [22].
Discussion
It has been shown that there is a moderate efﬂux of glu-
tamine from the human brain [23, 24] and thus there must
be an anaplerotic process that compensates for this since it
is essentially a loss of a-ketoglutarate (via glutamate) from
the TCA cycle and would lead to a stop of this cycle unless
another intermediate is channeled into the cycle. This
intermediate is typically oxaloacetate produced by pyru-
vate carboxylation [1]. To measure the anaplerotic contri-
bution, Mason et al. [15] measured
13C incorporation into
glutamate and glutamine in the occipital-parietal region of
awake humans while infusing [2-
13C]glucose, which labels
the C2 and C3 positions of glutamine and glutamate via
pyruvate carboxylase (and the pentose phosphate shunt).
Metabolic modeling of the labeling data indicated that
pyruvate carboxylase ﬂux is used for replacing glutamate
lost due to glutamine efﬂux and therefore can be consid-
ered to support neurotransmitter trafﬁcking. Oz et al. [26]
have reported a high pyruvate carboxylase rate of
approximately 0.14–0.18 lmol/gm/min contributing to the
glial TCA cycle ﬂux.
Is Pyruvate Carboxylation an Astrocyte Speciﬁc
Pathway?
Even though it has been shown that pyruvate carboxylation
in the brain is carried out primarily by the glial speciﬁc
enzyme PC and only to a minor extent by ME and PEPCK
[1] there is some debate about the cellular location of
pyruvate carboxylation.
13C MRS studies in rats injected
with
13C labeled lactate, predominantly a neuronal sub-
strate [27], showed that lactate was metabolized in a
compartment without measurable pyruvate carboxylation
[28, 29]. This can be interpreted as indicating that car-
boxylation is taking place in astrocytes. However, Hassel
and Brathe [30] concluded from experiments were large
amounts of lactate were infused that pyruvate was
carboxylated in neurons. The reason for this discrepancy is
not known.
In brain tissue slices carboxylation was also detected in
astrocytes [31, 32]. Guinea pig cortical tissue slices were
incubated with glucose and alanine which was labeled in
the C-2 position with
13C and the amino nitrogen was
15N
[21]. The
15N coupling could be seen in the
13CM R
spectrum [21]. The authors observed [2-
13C,
15N]aspartate,
but no [2-
13C]aspartate was detected [21]. There was very
little dilution of the
15N which would have had to be passed
to a glutamate intermediate in order to move from alanine
to aspartate. There was no detection of [3-
13C]aspartate
above natural abundance, which would have been found
50/50 with [2-
13C]aspartate if the
13C had been incorpo-
rated into aspartate via pyruvate deghydrogenase [21].
These data and those of others suggest that alanine is taken
up into an astrocytic compartment [21, 33–35]. Further-
more, it is clear from the results with [2-
13C,
15N]alanine
that aminotransferase and aspartate aminotransferase are
in very tight association with a pyruvate carboxylating
enzyme (Fig. 1).
Using primary mono cultures of neurons and astrocytes
it is possible to obtain information about the cellular
Fig. 1 Schematic presentation of reactions pertinent to pyruvate
carboxylation. This scheme illustrates how the concentrations of
pyruvate, oxaloacetate and 2-oxoglutarate, which are normally
relatively low, are important in regulating pyruvate carboxylation
and how these reactions can restore balance in these compounds (and
hence in the TCA cycle). For simplicity, malic enzyme is not
included. It can carboxylate malate to pyruvate and can theoretically
carry out the reverse reaction. * The bicarbonate pool is fed by all
decarboxylation reactions from the tricarboxylic acid cycle. AspAT
aspartate amino transferase, AlaAT alanine amino transferase, GDH
glutamate dehydrogenase, Lac lactate, LDH lactate dehydrogenase,
OAA oxaloacetate, PAG phosphate activated phosphatase, PC pyru-
vate carboxylase, PEPCK phosphoenolpyruvate carboxykinase,
PK pyruvate kinase
Neurochem Res (2010) 35:1916–1921 1917
123location and magnitude of pyruvate carboxylation. Using
[1-
13C]glucose or [2-
13C]acetate as substrates in cultures of
cortical astrocytes and GABAergic neurons Sonnewald
et al. [36] showed pyruvate carboxylation in astrocytes but
not in neurons However, it should be noted that the inter-
pretation of results obtained in these studies is complicated
since oxaloacetate can be converted to citrate directly or
via several steps to fumarate and subsequent oxaloacetate
and citrate (back cycling) [37]. The latter pathway will lead
to scrambling of label due to the symmetrical fumarate
molecule. Merle et al. [37] suggested incomplete back
cycling for astrocytes and complete back cycling for cer-
ebellar neurons. If back cycling in neurons is indeed
complete, the study above, utilizing [1-
13C]glucose, was
not capable of showing carboxylation in neurons. Waage-
petersen et al. [22] have performed a study using
[U-
13C]glucose plus [U-
13C]lactate and 3-nitropropionic
acid (3-NPA) to speciﬁcally block the TCA cycle at the
succinate dehydrogenase step [38–40]. In this way multiple
cycling of TCA cycle constituents was avoided and car-
boxylation would be clearly detected in labeling of the C-3
position, regardless of back cycling. Analyzing the labeling
patterns in amino acids, pyruvate carboxylation was
detected in astrocytes but not in neurons [22]. The authors
stated: ‘‘Based on the present results it may be safely
concluded that neuronal pyruvate carboxylation is unlikely
to play an important quantitative role. Therefore it is also
unlikely to be able to sustain release of transmitter gluta-
mate in cerebellar granule neurons, a process which is
quantitatively demanding.’’
What Factors Affect Pyruvate Carboxylation?
Depolarization, depresses transmission in glutamatergic
neurons, activates astrocytes but has less effect on GAB-
Aergic neurons [41–44]. Using brain slices it was shown
that depolarization did not affect carboxylation [25]. This
indicates that a mostly astrocytic workload doesn’t involve
increased pyruvate carboxylation. Furthermore, the pres-
ence of GABAB or GABAC ligands had no effect on
pyruvate carboxylation in brain slices [45, 46].
Increased Carboxylation
Zwingman [47] showed that increased ammonia concen-
tration increased pyruvate carboxylation both in astrocytes
in culture and in animal models. This carboxylation might
be coupled to the increased glutamine formation which is
a hallmark of ammonia detoxiﬁcation [47]. Glutamine
formation is the only efﬁcient method of ammonia ﬁxation
in brain.
The effect of ketone bodies on pyruvate carboxylation
by rat brain mitochondria has been investigated [1].
Meloetal.[48]showedthatpyruvatecarboxylationincreased
after rats were fed a ketogenic diet. This increase in carbox-
ylation was coupled to an increased pyruvate recycling.
Activation of the glutamatergic AMPA receptor induces
large post-synaptic action potentials [49] and should
therefore stimulate release of neurotransmitter glutamate.
In experiments with brain tissue slices metabolizing
[1-
13C]glucose it was possible to show evidence of pyru-
vate carboxylation in aspartate [50]. Increased carboxyla-
tion was detected when the slices were incubated with
AMPA or exogenous glutamate [50] suggesting that
increased neuronal work increases carboxylation. These
results contrast with the above mentioned results using K
?
depolarization where no increased carboxylation was
detected and where the workload is greater in astrocytes.
Interestingly, inhibition of the monocarboxylate transport-
ers MCT1 and MCT2 using AR-C122982 at 10 nM
increased carboxylation signiﬁcantly but increasing the
inhibition further by using 100 nM AR-C122982 reduced
carboxylation [50].
Decreased Carboxylation
Decreased carboxylation has been reported after penty-
lenetetrazole (PTZ) injection in rats [51]. PTZ adminis-
tration is generally used as a seizure model, but when low
doses are used it can cause anxiety [51]. Interestingly, the
antiepileptic drug carbamazepine (CBZ) decreased biotin
concentration in both humans and rats and decreased
pyruvate carboxylase activity in rat brain [52]. These
results support the use of biotin supplementation as a
concurrent strategy during CBZ administration to help
maintain pyruvate carboxylation and other important
metabolic pathways.
Not surprisingly, ischemia has a profound effect on
carboxylation, a pathway dependent on ATP concentration.
In rats subjected to 120 min of middle cerebral artery
occlusion followed by 120 min of reperfusion it could be
shown that use of astrocytic precursors originating from the
pyruvate carboxylase pathway was markedly reduced
compared to the pyruvate dehydrogenase pathway in glu-
tamate, and completely stopped in GABA in the ischemic
core area [53]. Furthermore, in the reperfused penumbra
glutamatergic and GABAergic neurons used relatively
more astrocytic metabolites derived from the pyruvate
carboxylase pathway than in the ischemic core [53]. The
pyrrolopyrimidine lipid peroxidation inhibitor, U-101033E
was administered to rats after middle cerebral artery
occlusion and was shown to speciﬁcally decrease mito-
chondrial pyruvate metabolism via both pyruvate dehy-
drogenase and pyruvate carboxylase pathways [54]. In the
canine cardiac arrest model of global ischemia carboxyla-
tion was decreased in the hippocampus in animals that had
1918 Neurochem Res (2010) 35:1916–1921
123undergone hyperoxic resuscitation [55]. Scaﬁdi et al. [56],
showed that labeling via PC was signiﬁcantly decreased
after traumatic brain injury in immature rats (a model of
pediatric traumatic brain injury).
Qu et al. [57] showed that exogenous glutamate had an
inhibiting effect on pyruvate carboxylation in astrocytes,
presumably by formation of oxaloacetate from 2-oxoglu-
tarate derived from glutamate. Inhibition of pyruvate car-
boxylation was also observed when glutamine was added to
astrocytes [58]. When metabolism of
13C labeled glucose
and lactate was investigated in cultured mouse cerebellar
astrocytes, it could be shown that carboxylation of pyruvate
using glucose as the precursor was more important for
biosynthesis of releasable glutamine and citrate, compared
with their intracellular pools [59].
Incubation of brain slices with increasing amounts of
the solvent dimethylsulphoxide (DMSO) which induces a
workload on the mitochondria via an unknown mechanism
showed decreased carboxylation of aspartate with
increasing amounts of DMSO [60]. This was the case
despite increasing ﬂux through the TCA cycle and
increased incorporation of label into glutamine via pyru-
vate dehydrogenase [60]. Thus, where the increased
activity was not due to glutamatergic load, there was no
increase (indeed there was a decrease) in pyruvate
carboxylation.
Conclusion
Taken together, these data support the assumption that
anaplerotic activity is increased due to glutamatergic
activity but that loss of four carbon molecules due to
GABAergic, mitochondrial or astrocytic activity is mini-
mal, due to the reuptake of GABA into the synaptic ter-
minal. It can be concluded that pyruvate carboxylation is
an extraordinarily important predominantly astrocytic
pathway.
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